Periodic Reporting for period 1 - SUBTREAT (Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorder)

Major depressive disorder (MDD) is a leading contributor to disability and suicide. It is the most costly brain disorder in Europe. Although multiple treatments are of proven efficacy, individual responses to treatments vary considerably and MDD recurrence is common. There is...